Traders Buy Monsanto (MON) on Weakness
Traders purchased shares of Monsanto Company (NYSE:MON) on weakness during trading hours on Friday. $257.55 million flowed into the stock on the tick-up and $139.97 million flowed out of the stock on the tick-down, for a money net flow of $117.58 million into the stock. Of all companies tracked, Monsanto had the 16th highest net in-flow for the day. Monsanto traded down ($0.50) for the day and closed at $117.35
MON has been the topic of several research reports. UBS cut Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 target price on the stock. in a research note on Friday, August 18th. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $131.00 target price on the stock in a research note on Tuesday, August 29th. BMO Capital Markets restated a “buy” rating and issued a $128.00 target price on shares of Monsanto in a research note on Friday, September 1st. Finally, Jefferies Group restated a “hold” rating and issued a $128.00 target price on shares of Monsanto in a research note on Friday, September 15th. Twelve analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $124.61.
The firm has a market capitalization of $51,660.00, a P/E ratio of 21.35, a PEG ratio of 1.70 and a beta of 1.04. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.35 and a quick ratio of 0.83.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company had revenue of $2.69 billion for the quarter, compared to analysts’ expectations of $2.51 billion. During the same quarter in the prior year, the business posted $0.07 EPS. The business’s revenue was up 4.8% compared to the same quarter last year. equities research analysts expect that Monsanto Company will post 5.74 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date of this dividend is Thursday, January 4th. Monsanto’s dividend payout ratio is currently 42.52%.
In related news, EVP Steven Mizell sold 11,526 shares of the business’s stock in a transaction that occurred on Monday, October 9th. The stock was sold at an average price of $119.70, for a total transaction of $1,379,662.20. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Duraiswami Narain sold 2,860 shares of the business’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.00, for a total value of $343,200.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 49,236 shares of company stock worth $5,931,934. Company insiders own 0.79% of the company’s stock.
Hedge funds have recently bought and sold shares of the stock. Parametric Portfolio Associates LLC grew its holdings in Monsanto by 2.8% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 926,114 shares of the basic materials company’s stock valued at $110,967,000 after buying an additional 25,101 shares in the last quarter. Steward Partners Investment Advisory LLC acquired a new position in Monsanto in the 3rd quarter valued at $356,000. Public Employees Retirement System of Ohio grew its holdings in Monsanto by 1.0% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 316,002 shares of the basic materials company’s stock valued at $37,863,000 after buying an additional 3,201 shares in the last quarter. Davis Selected Advisers grew its holdings in Monsanto by 0.4% in the 3rd quarter. Davis Selected Advisers now owns 428,111 shares of the basic materials company’s stock valued at $51,296,000 after buying an additional 1,911 shares in the last quarter. Finally, Americafirst Capital Management LLC acquired a new position in Monsanto in the 3rd quarter valued at $148,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: “Traders Buy Monsanto (MON) on Weakness” was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.watchlistnews.com/traders-buy-monsanto-mon-on-weakness/1766592.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with Analyst Ratings Network's FREE daily email newsletter.